We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Investec Plc | LSE:INVP | London | Ordinary Share | GB00B17BBQ50 | ORD GBP0.0002 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-7.50 | -1.45% | 511.50 | 512.50 | 513.50 | 529.00 | 512.50 | 529.00 | 441,712 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Commercial Banks, Nec | 1.3B | 292.79M | 0.3267 | 15.70 | 4.6B |
Date | Subject | Author | Discuss |
---|---|---|---|
07/1/2022 16:04 | Just in and had a look at the N91 share price. It was 280p a couple of days ago, wonder if that's INVP now selling off the 15%? If so, may get a bargain price in N91 shares at the end of the selloff. | mo123 | |
06/1/2022 15:41 | im thinking of jacking in voda and sgc and putting in here....interest rate rises on horizon too | nemesis6 | |
06/1/2022 11:39 | Those figures make me want to part with a huge chunk of savings, but learnt before that some apparently very cheap shares don't progress straightforwardly. Mind you, its tripled before from low bases. Is there a cheaper share on the market based on fundamentals and forecasts ? | yump | |
06/1/2022 11:20 | Updated broker consensus for the next financial year 2022-23. (based on a share price of 416p, fig's rounded) EPS 56p. Div 24.5p (yield of 6%) PE 7.5 Following year 2023-24 EPS 63p. Div 27p (yield of 6.7%) PE 6.6 Don't blame me if it doesn't pan out that way, but they are quite impressive figures when you look at the total return over the period. | mo123 | |
04/1/2022 23:33 | Someone selling out after noon put a hard cap on the price. There'll be a profit-taking correction when demand slackens off a bit IMO. | cassini | |
04/1/2022 16:56 | Remarkably stable steps upwards for a long time now, for a relatively large business. | yump | |
04/1/2022 16:38 | OK cheers Skinny. If the payout occurs around the time of the final results and we also get a final div of say 12p. It's a nice combined max total payout of around 47p. This assumes that they will not use the capital to initiate a share buyback. | mo123 | |
04/1/2022 13:20 | Those figures tally with those held on AFN. | skinny | |
04/1/2022 12:56 | Thanks for that nice to have it confirmed. | yump | |
04/1/2022 12:36 | If I remember correctly INVP have 700M shares and N91 had around 620M. Apol's if these fig's are incorrect. N91 share price at £2.70 x (620M x .15) = £2.70 x 93M shares = £250M (Assuming you could sell that number of shares at £2.70, which is unlikely) £250M/700M INVP shares = 35p All fig's approx. However, there is also the possibility that a transfer of shares takes place. Think Aleman also worked it out around 35p. | mo123 | |
04/1/2022 10:32 | Will the N91 distribution worth about 30p per share, or have my calcs. gone to pot ? | yump | |
27/12/2021 11:35 | Fintech should also see strong growth in SA next year Meanwhile at home: Goldman Sachs predict the UK will grow by 4.8pc in 2022, well above the 3.5pc predicted for the US, 4pc for Germany and 4.4pc for both France and Italy. | mo123 | |
23/12/2021 09:11 | Testing new ground above 400p. More to come I suspect. | its the oxman | |
20/12/2021 12:11 | Moderna vaccine shows good results against Omic. | mo123 | |
17/12/2021 09:34 | Thanks for the link :- "As it stands, hospitalisations and death rates are much lower in the Omicron wave than any other bout of COVID – and that’s being pinned on two things: South Africans, either through previous infection or by receiving the vaccine, collectively have a bigger wall of protection against COVID-19 – slowing down the rate of hospital admissions. However, there’s growing evidence that the Omicron variant itself is naturally milder than its predecessors – which would be fantastic news for the entire world, if this holds true. Phaahla acknowledged these factors on Friday". | skinny | |
17/12/2021 09:33 | This is the latest info I have Aleman, we may have to wait until tuesday to get a fuller picture. | mo123 | |
17/12/2021 09:05 | Would it be because S.African new cases look like they might be peaking? Yesterday's figure was 11% up on a week prior. Gauteng Province figures look like they peaked a week ago so it looks like the rest of the country is following on a week behind. Figures for S.A. are bit lumpy so treat with caution but they look a much improved trend on the surface. | aleman | |
17/12/2021 08:55 | N91 rising quickly this morning. No idea why? Indirectly helps holders of INVP get a better return. | mo123 | |
16/12/2021 13:19 | Yes indeed. Hopefully it will put Financials on a run in the first coupe of months of 2022 leading up to results. | boozey | |
16/12/2021 12:55 | Fabrice Montagne, chief U.K. economist at Barclays said. “Another hike in February of 25 basis points is well on the cards." Assuming of course that covid does not derail the economy too much. Good news for financials. | mo123 | |
12/12/2021 10:42 | Was reading some papers this morning about the OM variant in SA since it was mentioned above, and so far, the papers I have read, mainly refer to how mild it is compared to Delta, altough admittedly this may change. It could end up being a lot worse here in the UK, as we move into winter, SA basks in summer sunshine. | mo123 | |
10/12/2021 15:19 | Great summary Mo. Investec seems to be performing better now than before the pandemic but at a significantly lower share price although the divestment of N91 makes it hard to make a like for like comparison. Either way a strong hold for me into the new year with the dividend to come and as you say some N91 shares. | boozey | |
09/12/2021 09:11 | Morning all, quick off the cuff ramble on xd day. The co. is already on a low PE from earnings expected to hit around 50p this year. Plus we still have to receive the proceeds from N91. Africa is expected to be one of the fastest growing continents over the next 5 years because of its high birth rate. INVP also operates on a global scale so it is well diversified and has a high NAV. Of course this will be reduced by the sale of 15% in N91. Brokers price target has a mean of around 470p. The mkt is now expecting an int rate rise in UK Feb22. Pfizer building a manufacturing facility in SA due to open next year should also help contain the worst of the virus. The company is,however,dual registered and has operations in a country where reform is slow and debt is high, ( could weaken value of the rand and earnings if it gets worse) but it is mainly a SA gov't dilemma to solve. Just look, however, at the UK & US debt as a % of GDP. | mo123 | |
08/12/2021 23:28 | Mister MD, I agree. I thought the SA situation may impact the share price negatively at least for a period but it hasn’t turned out that way and still some way to go to get back to ore-pandemic prices. Ex-dividend in the morning. | boozey |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions